DE602004014261D1 - Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten - Google Patents
Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheitenInfo
- Publication number
- DE602004014261D1 DE602004014261D1 DE602004014261T DE602004014261T DE602004014261D1 DE 602004014261 D1 DE602004014261 D1 DE 602004014261D1 DE 602004014261 T DE602004014261 T DE 602004014261T DE 602004014261 T DE602004014261 T DE 602004014261T DE 602004014261 D1 DE602004014261 D1 DE 602004014261D1
- Authority
- DE
- Germany
- Prior art keywords
- disorders
- drd3
- diseases
- diagnostic
- related diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title 2
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 101000865224 Homo sapiens D(3) dopamine receptor Proteins 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 208000025966 Neurological disease Diseases 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 208000019423 liver disease Diseases 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000014001 urinary system disease Diseases 0.000 abstract 2
- 102100029808 D(3) dopamine receptor Human genes 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000049085 human DRD3 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/9413—Dopamine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03005465 | 2003-03-17 | ||
| PCT/EP2004/002183 WO2004082569A2 (en) | 2003-03-17 | 2004-03-04 | Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004014261D1 true DE602004014261D1 (de) | 2008-07-17 |
Family
ID=33016819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004014261T Expired - Lifetime DE602004014261D1 (de) | 2003-03-17 | 2004-03-04 | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1606633B1 (de) |
| AT (1) | ATE397755T1 (de) |
| DE (1) | DE602004014261D1 (de) |
| ES (1) | ES2308157T3 (de) |
| WO (1) | WO2004082569A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116459341B (zh) * | 2023-03-15 | 2024-03-19 | 徐州医科大学 | 多巴胺3型受体作为靶点在开发或制备非阿片类镇痛药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2663638B2 (fr) * | 1990-04-06 | 1995-02-10 | Institut Nal Sante Recherc Medic | Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides. |
| DE69434492T2 (de) * | 1993-03-10 | 2006-07-13 | Smithkline Beecham Corp. | Phosphodiesterase des menschlichen gehirns |
| TWI274750B (en) * | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| DE19922443A1 (de) * | 1999-05-07 | 2000-11-09 | Basf Ag | Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen |
-
2004
- 2004-03-04 DE DE602004014261T patent/DE602004014261D1/de not_active Expired - Lifetime
- 2004-03-04 ES ES04717063T patent/ES2308157T3/es not_active Expired - Lifetime
- 2004-03-04 AT AT04717063T patent/ATE397755T1/de not_active IP Right Cessation
- 2004-03-04 EP EP04717063A patent/EP1606633B1/de not_active Expired - Lifetime
- 2004-03-04 WO PCT/EP2004/002183 patent/WO2004082569A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ATE397755T1 (de) | 2008-06-15 |
| ES2308157T3 (es) | 2008-12-01 |
| EP1606633B1 (de) | 2008-06-04 |
| WO2004082569A2 (en) | 2004-09-30 |
| WO2004082569A3 (en) | 2004-12-02 |
| EP1606633A2 (de) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
| EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| EP2017620A3 (de) | Diagnostika und Therapeutika für mit Dipeptidyl-peptidase 1 (DPP1) assoziierten Krankheiten | |
| WO2007147497A3 (en) | Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target | |
| DE602004017439D1 (de) | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten | |
| WO2004097358A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) | |
| WO2005050225A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84) | |
| DE602004014261D1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten | |
| ATE554393T1 (de) | Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen | |
| WO2005040211A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) | |
| WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
| WO2005108998A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) | |
| WO2004104577A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) | |
| DE602004013770D1 (de) | Diagnostik- und therapie- verfahren von mit pils verbundenen krankheiten | |
| WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
| WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
| WO2004106934A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) | |
| WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) | |
| WO2004097034A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4) | |
| WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
| DE602004014254D1 (de) | Diagnostik- und therapie- verfahren von mit 5-ht1f rezeptor verbundenen haematologischen krankheiten | |
| WO2004082574A3 (en) | Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) | |
| WO2005040824A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24) | |
| WO2007141005A8 (en) | Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE |